Outcomes in Pregnant Adolescent Patients Infected With SARS-CoV-2

被引:2
|
作者
Nguyen, Anh Quynh [1 ]
Murrin, Ellen [1 ]
Nasrallah, Sebastian [1 ]
Hitchings, Laura [2 ]
Wang, Jenny Q. [1 ]
VanDillen, Michael B. [3 ]
Eletu, Oluwafunmilayo [4 ]
Maxwell, G. Larry [1 ]
Gomez, Luis M. [1 ]
机构
[1] Inova Hlth Syst, Womens Hlth Integrated Res Ctr, Dept Obstet & Gynecol, Falls Church, VA USA
[2] Advarra, Sect IRB Serv, Columbia, MD USA
[3] Univ Tennessee Hlth Sci Ctr, Dept Obstet & Gynecol, Memphis, TN USA
[4] Univ Virginia, Sch Med, Dept Obstet & Gynecol, Charlottesville, VA USA
关键词
COVID-19; pregnancy; adolescents; MORTALITY; COVID-19; CHILDREN;
D O I
10.1097/INF.0000000000003988
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background:Pregnant patients with coronavirus disease 2019 (COVID-19) are at risk for adverse pregnancy outcomes. Although clinical outcomes for pregnant adults have been reported, the impact of COVID-19 on adolescents is lacking. We sought to evaluate obstetric outcomes of pregnant adolescents infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and compare them with uninfected adolescent controls. Methods:Retrospective cohort study of pregnant adolescents (14-19 years) who had a positive polymerase chain reaction test for SARS-CoV-2 from April 2020 to December 2020 at Inova Health System Hospitals. Controls included pregnant adolescents who tested negative. The primary outcome was a composite of preeclampsia, preterm delivery, cesarean delivery, fetal growth restriction and stillbirth. Secondary outcomes included maternal and neonatal morbidity. Results:Forty-eight pregnant adolescents who tested positive for SARS-CoV-2 were compared with 394 controls. Infected adolescents were more likely to be Hispanic (91.67% vs. 12.18%; risk ratio [RR] 41.85 [95% CI: 15.43-113.5]) and uninsured (50% vs. 7.87%; RR 7.04 [95% CI: 4.31-11.49]. Nearly 80% of infected adolescents remained asymptomatic, whereas one-third of symptomatic adolescents progressed to severe or critical COVID-19. The primary composite outcome was more prevalent in infected adolescents compared with noninfected controls (41.67% vs. 25.38%; adjusted RR 2.65 [95% CI: 1.19-5.93]). Maternal morbidity was more prevalent in infected adolescents (6.25% vs. 0.76%; adjusted RR 9.53 [95% CI: 3.83-23.71]). Primary and secondary maternal outcomes were more prevalent in younger adolescents and those with higher severity of COVID-19. Maternal SARS-CoV-2 infection was not associated with neonatal morbidity. Conclusions:Pregnant adolescents infected with SARS-CoV-2 are more likely to have adverse obstetric outcomes and maternal morbidity compared with noninfected pregnant adolescents.
引用
收藏
页码:781 / 786
页数:6
相关论文
共 50 条
  • [21] Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women
    Cruz-Lemini, Monica
    Ferriols Perez, Elena
    de la Cruz Conty, Maria Luisa
    Cano Aguilar, Africa
    Encinas Pardilla, Maria Begona
    Prats Rodriguez, Pilar
    Muner Hernando, Marta
    Forcen Acebal, Laura
    Pintado Recarte, Pilar
    Medina Mallen, Maria del Carmen
    Perez Perez, Noelia
    Canet Rodriguez, Judit
    Villalba Yarza, Ana
    Nieto Velasco, Olga
    del Barrio Fernandez, Pablo Guillermo
    Orizales Lago, Carmen Maria
    Marcos Puig, Beatriz
    Munoz Abellana, Begona
    Fuentes Ricoy, Laura
    Rodriguez Vicente, Agueda
    Janeiro Freire, Maria Jesus
    Alferez Alvarez-Mallo, Macarena
    Casanova Pedraz, Cristina
    Alomar Mateu, Onofre
    Lesmes Heredia, Cristina
    Wizner de Alva, Juan Carlos
    Posadas San Juan, Alma
    Macia Badia, Montserrat
    Alvarez Colomo, Cristina
    Sanchez Munoz, Antonio
    Pratcorona Alicart, Laia
    Alonso Saiz, Ruben
    Lopez Rodriguez, Monica
    Barbancho Lopez, Maria Carmen
    Meca Casbas, Marta Ruth
    Vaquerizo Ruiz, Oscar
    Moran Antolin, Eva
    Nunez Valera, Maria Jose
    Fernandez Fernandez, Camino
    Tubau Navarra, Albert
    Cano Garcia, Alejandra Maria
    Soldevilla Perez, Susana
    Gattaca Abasolo, Irene
    Adanez Garcia, Jose
    Puertas Prieto, Alberto
    Ostos Serna, Rosa
    Guadix Martin, Maria del Pilar
    Catalina Coello, Monica
    Espuelas Malon, Silvia
    Sainz Bueno, Jose Antonio
    VIRUSES-BASEL, 2021, 13 (01):
  • [22] Perinatal outcomes of pregnant women having SARS-CoV-2 infection
    Arinkan, Sevcan Arzu
    Alper, Ezgi Ceren Dalli
    Topcu, Gunes
    Muhcu, Murat
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2021, 60 (06): : 1043 - 1046
  • [23] Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection
    Saccone, Gabriele
    Sen, Cihat
    Di Mascio, Daniele
    Galindo, Alberto
    Grunebaum, Amos
    Yoshimatsu, Jun
    Stanojevic, Milan
    Kurjak, Asim
    Chervenak, Frank
    Rodriguez Suarez, Maria Jose
    Maria Gambacorti-Passerini, Zita
    Anaya Baz, Maria de los Angeles
    Aguilar Galan, Esther Vanessa
    Cunarro Lopez, Yolanda
    De Leon Luis, Juan Antonio
    Cueto Hernandez, Ignacio
    Herraiz, Ignacio
    Villalain, Cecilia
    Venturella, Roberta
    Rizzo, Giuseppe
    Mappa, Ilenia
    Gerosolima, Giovanni
    Hellmeyer, Lars
    Koenigbauer, Josefine
    Ameli, Giada
    Frusca, Tiziana
    Volpe, Nicola
    Luca Schera, Giovanni Battista
    Fieni, Stefania
    Esposito, Eutalia
    Simonazzi, Giuliana
    Di Donna, Gaetana
    Youssef, Aly
    Della Gatta, Anna Nunzia
    Di Donna, Mariano Catello
    Chiantera, Vito
    Buono, Natalina
    Sozzi, Giulio
    Greco, Pantaleo
    Morano, Danila
    Bianchi, Beatrice
    Marino, Maria Giulia Lombana
    Laraud, Federica
    Ramone, Arianna
    Cagnacci, Angelo
    Barra, Fabio
    Gustavino, Claudio
    Ferrero, Simone
    Ghezzi, Fabio
    Cromi, Antonella
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2021, 57 (02) : 232 - 241
  • [24] Laboratory characteristics of pregnant compared to non-pregnant women infected with SARS-CoV-2
    Aya Mohr-Sasson
    Jennifer Chayo
    Yossi Bart
    Raanan Meyer
    Eyal Sivan
    Shali Mazaki-Tovi
    Yoav Yinon
    Archives of Gynecology and Obstetrics, 2020, 302 : 629 - 634
  • [25] Laboratory characteristics of pregnant compared to non-pregnant women infected with SARS-CoV-2
    Mohr-Sasson, Aya
    Chayo, Jennifer
    Bart, Yossi
    Meyer, Raanan
    Sivan, Eyal
    Mazaki-Tovi, Shali
    Yinon, Yoav
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 302 (03) : 629 - 634
  • [26] QUALITY OF LIFE IN PREGNANT WOMEN INFECTED WITH SARS-COV-2 AND ORAL HEALTH
    Schaas, Carmina
    Mitrea, Mihaela
    Dmour, Allia
    Forna, Norina Consuela
    Walid, Edlibi Al Hage
    Maxim, Radu Razvan
    Saveanu, Iulia Catalina
    ROMANIAN JOURNAL OF ORAL REHABILITATION, 2021, 13 (03): : 184 - 192
  • [27] How should we treat pregnant women infected with SARS-CoV-2?
    Faure-Bardon, V
    Salomon, L. J.
    Leruez-Ville, M.
    Ville, Y.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 127 (09) : 1050 - 1052
  • [28] Ayurvedic management of pregnant woman infected with SARS-CoV-2 - A case report
    Pandey, Meenakshi
    Kajaria, Divya
    Sharma, Charu
    Kadam, Sujata
    JOURNAL OF AYURVEDA AND INTEGRATIVE MEDICINE, 2022, 13 (01)
  • [29] Getting infected with SARS-CoV-2
    Polastri, Massimiliano
    INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION, 2022, 29 (02):
  • [30] Is the Patient Infected with SARS-CoV-2?
    Klausner, Jeffrey D.
    Kojima, Noah
    Butler-Wu, Susan M.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2021, 59 (04)